Form 4: T2 Biosystems Director Robin Toft Receives 25,000 Restricted Stock Units
SEC Form 4 Filing
Director Robin Toft of T2 Biosystems was granted 25,000 restricted stock units (RSUs) that vest in two equal annual installments starting November 4, 2025.
Summary
- T2 Biosystems director, Robin Toft, received 25,000 restricted stock units (RSUs) on November 4, 2024.
- These RSUs will vest in two equal annual installments, beginning on November 4, 2025.
- The grant was contingent on stockholder approval of the amendment and restatement of the company's 2014 Incentive Award Plan.
- Stockholder approval for the plan amendment was obtained on December 30, 2024.
Sentiment
Score: 7
Explanation: The document reflects a standard compensation practice, which is generally viewed positively as it aligns director interests with shareholders. There are no negative implications.
Positives
- The grant of RSUs to a director aligns their interests with the long-term success of the company.
- The vesting schedule encourages continued service and contribution from the director.
Industry Context
The granting of stock-based compensation to directors is a common practice in the biotechnology industry to align their interests with shareholders and incentivize long-term value creation.
Comparison to Industry Standards
- Stock-based compensation, such as RSUs, is a standard practice for compensating directors in publicly traded companies, particularly in the biotech sector.
- The vesting schedule of two equal annual installments is also a common approach to ensure continued service and commitment from directors.
- Companies like Exact Sciences and Illumina also use similar stock-based compensation plans for their directors.
Stakeholder Impact
- Shareholders may view the RSU grant positively as it aligns director interests with the company's long-term performance.
- The grant does not have a direct impact on employees, customers, suppliers, or creditors.
Key Dates
| Date | Description |
|---|---|
| 11/04/2024 | Date of the RSU grant to Robin Toft. |
| 11/04/2025 | First vesting date for half of the granted RSUs. |
| 12/30/2024 | Date of stockholder approval for the amendment and restatement of the 2014 Incentive Award Plan. |
| 01/02/2025 | Date of the filing of the SEC Form 4. |
Keywords
Restricted Stock Units, RSU, Director Compensation, Incentive Award Plan, Stockholder Approval, T2 Biosystems, Robin Toft
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.